[HTML][HTML] Cell-based therapy for the treatment of glioblastoma: an update from preclinical to clinical studies

N Attia, M Mashal, S Pemminati, A Omole… - Cells, 2021 - mdpi.com
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies

N Attia, M Mashal, S Pemminati, A Omole… - Cells, 2022 - search.proquest.com
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies

N Attia, M Mashal, S Pemminati, A Omole… - 2022 - agris.fao.org
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

[HTML][HTML] Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies

N Attia, M Mashal, S Pemminati, A Omole… - Cells, 2022 - ncbi.nlm.nih.gov
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies

N Attia, M Mashal, S Pemminati, A Omole… - Cells, 2021 - archive.sdpublishers.com
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies.

N Attia, M Mashal, S Pemminati, A Omole… - Cells (2073 …, 2022 - search.ebscohost.com
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies

N Attia, M Mashal, S Pemminati, A Omole… - Cells, 2021 - pubmed.ncbi.nlm.nih.gov
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies

N Attia, M Mashal, S Pemminati, A Omole… - Cells, 2021 - eprint.subtopublish.com
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies.

N Attia, M Mashal, S Pemminati, A Omole… - Cells, 2021 - europepmc.org
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

[PDF][PDF] Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies. Cells 2021, 11, 116

N Attia, M Mashal, S Pemminati, A Omole… - 2021 - researchgate.net
Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …